Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HW.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HW.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GB.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.72NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FE.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FE.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used